Feb
12
2020
On demand

Multi-modal facilities: delivering flexible, future-proof ATMP manufacturing

Between newly developed products, strategic partnerships, and acquisitions in the Advanced Therapy Medicinal Market, companies are racing to find or create capacity for plasmids, viral vectors, gene modified cell therapies, and fill finish.

Owner companies and entrepreneurs are considering building multi-product or multi-tenet ATMP facilities to meet this emerging demand.

A dedicated manufacturing facility can be costly, and limits options for the future. Why not have a facility that can produce multiple product types to allow for adaptability to an evolving product pipeline?

Attendees learn:

  • What the future of the “flexible facility” truly looks like for companies with multi-product types
  • How to scale appropriately to achieve faster speed-to-market, lower costs and ultimate manufacturing flexibility

Emily Thompson
Process Engineer
Noel Maestre
Director, ATMP at CRB

SPEAKERS

Emily Thompson
Process Engineer
Noel Maestre
Director, ATMP at CRB

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
36
Days
7
Hrs
8
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
14
Days
7
Hrs
8
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
9
Days
7
Hrs
8
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
7
Days
7
Hrs
8
Min
Register

Strategic partnering to enable cell therapy commercialization

J Smith
X de Mollerat du Jeu
Jenessa Smith
Jenessa Smith
Associate Director of Process Development at ArsenalBio
Xavier de Mollerat du Jeu
Xavier de Mollerat du Jeu
Senior Director, R&D, Cell and Gene Therapy at Thermo Fisher Scientific
12 May 2022
Watch now